Chelsea Therapeutics Earnings: Loss Narrowed

Chelsea Therapeutics International Ltd. ‘s (NASDAQ:CHTP) second quarter loss narrowed, beating estimates. Chelsea Therapeutics International is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of innovative pharmaceutical products.

Investing Insights: Is TV the Next Bullish Catalyst for Apple’s Stock?

Chelsea Therapeutics International Ltd. Earnings Cheat Sheet

Results: Loss narrowed to $7.9 million (loss of 12 cents per diluted share) from $13.3 million (loss of 21 cents per share) in the same quarter a year earlier.

Actual vs. Wall St. Expectations: Chelsea Therapeutics International Ltd. beat the mean analyst estimate of a loss of 19 cents per share.

Key Stats:

The company beat estimates last quarter after meeting expectations in the first quarter with a loss of 23 cents per share.

Looking Forward: Analysts seem more positive about the company’s results for the next quarter than three months ago. The average estimate for the third quarter has moved from a loss of 22 cents a share to a loss of 17 cents over the last ninety days. The average estimate for the fiscal year is now 76 cents per share, a rise from the 87 cents predicted ninety days ago.

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute — click here and get our CHEAT SHEET stock picks now.

(Company fundamentals provided by Xignite Financials. Earnings estimates provided by Zacks)

Don’t Miss These Additional Hot Stories:

The Mining Industry Welcomes Central Bank QE

Is Chevron’s Stock a Buy Now?

Facebook: Fake Out?